Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer.
Moreira RS, da Silva MM, de Melo Vasconcelos CF, da Silva TD, Cordeiro GG, Mattos-Jr LAR, da Rocha Pitta MG, de Melo Rêgo MJB, Pereira MC.
Moreira RS, et al. Among authors: da silva td.
J Cancer Res Clin Oncol. 2023 Dec;149(19):17651-17661. doi: 10.1007/s00432-023-05437-z. Epub 2023 Oct 16.
J Cancer Res Clin Oncol. 2023.
PMID: 37843557
Review.